<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02149212</url>
  </required_header>
  <id_info>
    <org_study_id>IDPC_2 2014</org_study_id>
    <nct_id>NCT02149212</nct_id>
  </id_info>
  <brief_title>Iliac Vein Stenting in Advanced Chronic Venous Insufficiency</brief_title>
  <official_title>Randomized Double-blind Trial Between Clinical and Endovascular Treatment in Patients With Advanced Chronic Venous Insufficiency and Iliac Venous Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Dante Pazzanese de Cardiologia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      About 90 % of vascular symptoms affecting the lower limbs consist of venous diseases. Its
      highest incidence occurs from the second decade of life, affecting significantly the
      economically active population. Chronic Venous Insufficiency treatment aims to relieve
      symptoms, treat and prevent complications, prevent recurrences and provide cosmetic
      satisfaction with minimal side effects. It's current treatment includes some classic postural
      measures (leg elevation), elastic stockings and bandages compression therapy and possible
      medication (phlebotonics). The results in the medium and long term are unfavorable, since a
      large number of patients do not get better or evolves with recurrence of symptoms. Nowadays
      many, no prospective , not randomized , international studies have shown favorable results
      with endovascular treatment of obstruction in the iliac vein territory in patients with
      advanced Chronic Venous Insufficiency . The purpose of this prospective, double-blinded
      randomized study is to evaluate the results obtained with endovascular treatment, through the
      use of angioplasty and stenting in this group of patients when compared with clinical
      treatment .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in pain on the Pain Visual Analogue Sacale at 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Venous ulcer cicatrization at 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from the baseline Venous Clinical Severity Score at 6 month</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in SF-36 Quality of Life questionnaire at 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent integrity at 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent position at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Pelvic X-ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent patency at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Stent patency obtained with treated venous segment Duplex Scanning</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Iliac Vein Obstruction</condition>
  <condition>May-Thurner Syndrome</condition>
  <condition>Cockett Syndrome</condition>
  <arm_group>
    <arm_group_label>Clinical Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phlebotonics: Aminaftone 75 mg BID Limb elastic compression support (Elastic stockings: Venosan / Elastic Bandages: Atamed) Unna boot dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iliac vein stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wallstent</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phlebotonic</intervention_name>
    <description>Aminaftone -- 75 mg BID</description>
    <arm_group_label>Clinical Treatment</arm_group_label>
    <arm_group_label>Iliac vein stenting</arm_group_label>
    <other_name>Aminaftone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stent</intervention_name>
    <description>Iliac Vein Stenting</description>
    <arm_group_label>Iliac vein stenting</arm_group_label>
    <other_name>Wallstent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limb elastic compression support</intervention_name>
    <description>CEAP 3-5 &gt; 20-30 mmHg compression stockings CEAP 6 &gt; elastic bandages</description>
    <arm_group_label>Clinical Treatment</arm_group_label>
    <arm_group_label>Iliac vein stenting</arm_group_label>
    <other_name>Venosan compression stockings</other_name>
    <other_name>Atamed elastic bandages</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Unna boot dressing</intervention_name>
    <description>CEAP 6 &gt; Unna boot dressing</description>
    <arm_group_label>Clinical Treatment</arm_group_label>
    <arm_group_label>Iliac vein stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Advanced Chronic Venous Insufficiency (CEAP 3-6) submitted to clinical treatment for
             at least 1 year with no response.

          -  Subject must be &gt; 18 and &lt; 80 years of age

          -  Willing to participate in and able to understand, read and sign the informed consent
             document before the planned procedure

          -  On duplex ultrasound: patent common femoral vein, and patent deep femoral vein, and/or
             femoral vein of the study leg

        Exclusion Criteria:

          -  Subject cannot or will not provide written informed consent

          -  Previous venous stent implantation involving the study leg or inferior vena cava

          -  Previous venovenous bypass surgery involving the study leg

          -  Known metal allergy precluding endovascular stent implantation

          -  Known reaction or sensitivity to iodinated contrast that cannot be managed with
             premedication

          -  Subjects who are pregnant (women of childbearing potential must have a negative
             pregnancy test within 7 days prior to enrollment

          -  Acute deep venous thrombosis involving either leg

          -  Known history of chronic total occlusion of the common femoral vein of the study leg.

          -  Known history of thrombophilia (e.g., protein C or S deficiency, anti-thrombin III
             deficiency, presence of lupus anticoagulant, etc.)

          -  Venous compression caused by tumor encasement

          -  Venous outflow obstruction caused by tumor thrombus

          -  Life expectancy of less than 6 months

          -  Lower Extremity Arterial Insufficiency

          -  Elevated baseline blood creatinine (value greater than the upper limit of the normal
             range)

          -  Any concurrent disease or condition that, in the opinion of the Investigator, would
             make the subject unsuitable for participation in the study; examples include but are
             not limited to the inability to lie supine for the index procedure (e.g., severe
             congestive heart failure), thrombocytopenia or other hematological disorders
             associated with an unacceptable risk of bleeding, implanted orthopedic hardware that
             precludes proper imaging, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabio H Rossi, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Dante Pazzanese de Cardiologia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardilogia</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>04012-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Alhalbouni S, Hingorani A, Shiferson A, Gopal K, Jung D, Novak D, Marks N, Ascher E. Iliac-femoral venous stenting for lower extremity venous stasis symptoms. Ann Vasc Surg. 2012 Feb;26(2):185-9. doi: 10.1016/j.avsg.2011.05.033. Epub 2011 Oct 22.</citation>
    <PMID>22018502</PMID>
  </reference>
  <reference>
    <citation>Kölbel T, Lindh M, Akesson M, Wassèlius J, Gottsäter A, Ivancev K. Chronic iliac vein occlusion: midterm results of endovascular recanalization. J Endovasc Ther. 2009 Aug;16(4):483-91. doi: 10.1583/09-2719.1.</citation>
    <PMID>19702343</PMID>
  </reference>
  <reference>
    <citation>Raju S. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013 Apr;57(4):1163-9. doi: 10.1016/j.jvs.2012.11.084. Epub 2013 Feb 20. Review.</citation>
    <PMID>23433816</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <last_update_submitted>July 22, 2014</last_update_submitted>
  <last_update_submitted_qc>July 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Dante Pazzanese de Cardiologia</investigator_affiliation>
    <investigator_full_name>Fabio H Rossi</investigator_full_name>
    <investigator_title>PHD</investigator_title>
  </responsible_party>
  <keyword>Iliac</keyword>
  <keyword>Vein</keyword>
  <keyword>Stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Venous Insufficiency</mesh_term>
    <mesh_term>May-Thurner Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aminaftone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

